11224616

Source:http://linkedlifedata.com/resource/pubmed/id/11224616

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0032743, umls-concept:C0220825, umls-concept:C0279626, umls-concept:C0600558, umls-concept:C0871261, umls-concept:C1704632, umls-concept:C1706817, umls-concept:C2911692
pubmed:issue	3
pubmed:dateCreated	2001-3-6
pubmed:abstractText	To evaluate the use of positron emission tomography using [(18)F]-fluorodeoxyglucose (FDG-PET) to assess the response to neoadjuvant radiotherapy and chemotherapy in patients with locally advanced esophageal cancer.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/11224616-10091784, http://linkedlifedata.com/resource/pubmed/commentcorrection/11224616-10201455, http://linkedlifedata.com/resource/pubmed/commentcorrection/11224616-10355433, http://linkedlifedata.com/resource/pubmed/commentcorrection/11224616-10481766, http://linkedlifedata.com/resource/pubmed/commentcorrection/11224616-10560332, http://linkedlifedata.com/resource/pubmed/commentcorrection/11224616-10565769, http://linkedlifedata.com/resource/pubmed/commentcorrection/11224616-10693241, http://linkedlifedata.com/resource/pubmed/commentcorrection/11224616-10764429, http://linkedlifedata.com/resource/pubmed/commentcorrection/11224616-11224618, http://linkedlifedata.com/resource/pubmed/commentcorrection/11224616-11807374, http://linkedlifedata.com/resource/pubmed/commentcorrection/11224616-12560789, http://linkedlifedata.com/resource/pubmed/commentcorrection/11224616-1524915, http://linkedlifedata.com/resource/pubmed/commentcorrection/11224616-1605440, http://linkedlifedata.com/resource/pubmed/commentcorrection/11224616-2013803, http://linkedlifedata.com/resource/pubmed/commentcorrection/11224616-3712040, http://linkedlifedata.com/resource/pubmed/commentcorrection/11224616-6987040, http://linkedlifedata.com/resource/pubmed/commentcorrection/11224616-7459811, http://linkedlifedata.com/resource/pubmed/commentcorrection/11224616-7712984, http://linkedlifedata.com/resource/pubmed/commentcorrection/11224616-7751894, http://linkedlifedata.com/resource/pubmed/commentcorrection/11224616-7754623, http://linkedlifedata.com/resource/pubmed/commentcorrection/11224616-8194005, http://linkedlifedata.com/resource/pubmed/commentcorrection/11224616-8229124, http://linkedlifedata.com/resource/pubmed/commentcorrection/11224616-831755, http://linkedlifedata.com/resource/pubmed/commentcorrection/11224616-8929320, http://linkedlifedata.com/resource/pubmed/commentcorrection/11224616-9016218, http://linkedlifedata.com/resource/pubmed/commentcorrection/11224616-9225959, http://linkedlifedata.com/resource/pubmed/commentcorrection/11224616-9270638, http://linkedlifedata.com/resource/pubmed/commentcorrection/11224616-9307472, http://linkedlifedata.com/resource/pubmed/commentcorrection/11224616-9616140, http://linkedlifedata.com/resource/pubmed/commentcorrection/11224616-9667720, http://linkedlifedata.com/resource/pubmed/commentcorrection/11224616-9716038, http://linkedlifedata.com/resource/pubmed/commentcorrection/11224616-9717781, http://linkedlifedata.com/resource/pubmed/commentcorrection/11224616-9747816, http://linkedlifedata.com/resource/pubmed/commentcorrection/11224616-9776278, http://linkedlifedata.com/resource/pubmed/commentcorrection/11224616-9931627
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0372354
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Fluorodeoxyglucose F18, http://linkedlifedata.com/resource/pubmed/chemical/Radiopharmaceuticals
pubmed:status	MEDLINE
pubmed:month	Mar
pubmed:issn	0003-4932
pubmed:author	pubmed-author:AvrilNN, pubmed-author:BauerMM, pubmed-author:BrücherB LBL, pubmed-author:EGANJ PJP, pubmed-author:SchwaigerMM, pubmed-author:SiewertJ RJR, pubmed-author:SteinH JHJ, pubmed-author:WeberWW, pubmed-author:WernerMM, pubmed-author:ZimmermanFF
pubmed:issnType	Print
pubmed:volume	233
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	300-9
pubmed:dateRevised	2009-11-18
pubmed:meshHeading	pubmed-meshheading:11224616-Adult, pubmed-meshheading:11224616-Carcinoma, Squamous Cell, pubmed-meshheading:11224616-Chemotherapy, Adjuvant, pubmed-meshheading:11224616-Combined Modality Therapy, pubmed-meshheading:11224616-Esophageal Neoplasms, pubmed-meshheading:11224616-Female, pubmed-meshheading:11224616-Fluorodeoxyglucose F18, pubmed-meshheading:11224616-Humans, pubmed-meshheading:11224616-Male, pubmed-meshheading:11224616-Middle Aged, pubmed-meshheading:11224616-Neoadjuvant Therapy, pubmed-meshheading:11224616-Predictive Value of Tests, pubmed-meshheading:11224616-Prospective Studies, pubmed-meshheading:11224616-Radiopharmaceuticals, pubmed-meshheading:11224616-Radiotherapy, Adjuvant, pubmed-meshheading:11224616-Survival Analysis, pubmed-meshheading:11224616-Tomography, Emission-Computed, pubmed-meshheading:11224616-Treatment Outcome
pubmed:year	2001
pubmed:articleTitle	Neoadjuvant therapy of esophageal squamous cell carcinoma: response evaluation by positron emission tomography.
pubmed:affiliation	Chirurgische Klinik und Poliklinik, Klinikum rechts der Isar der Technischen Universität, Munich, Germany. bruecher@lrz.tu-muenchen.de
pubmed:publicationType	Journal Article, Evaluation Studies